HOME >> BIOLOGY >> NEWS
DNA transcription is tuned to specific cells

September 14, 2001 -- Researchers have found a new example of how the machinery that controls the transcription of DNA to messenger RNA (mRNA) is tailored to specific cells or genes.

In studies in mice, the researchers discovered that TAFII105, a key component of the transcription machinery, is specific to egg-forming cells in ovaries. The finding emphasizes a newly emerging theme in molecular biology -- that DNA transcription is not standardized throughout cells but is instead adapted to control cell-specific gene expression. The scientists believe that future research is likely to reveal other cell-specific transcription components that ensure that genes are expressed in a customized way according to the needs of each cell.

The finding that TAFII105 is specifically involved in controlling genes for egg formation also hints that some inherited forms of sterility in women may be due to mutations in the TAFII105 gene, said the scientists.

In an article published in the September 14, 2001, issue of the journal Science, Howard Hughes Medical Institute investigator Robert Tjian and colleagues Richard N. Freiman, Shane R. Albright, Shuang Zheng, William C. Sha and Robert E. Hammer detailed how they traced the transcriptional role of TAFII105 to granulosa cells in the ovaries of mice. Granulosa cells surround the developing egg, called the oocyte, and foster its development.

The scientists also used DNA microarrays to explore which genes were switched off in knockout mice that lacked a functional copy of the TAFII105 gene. The TAFII105 protein is one of a family of TAF proteins that are subunits of a large complex called the transcription factor TFIID.

"When TFIID and all its associated factors were discovered ten years ago, we found it in every cell we looked at," said Tjian, who is at the University of California at Berkeley. "We thought it would be invariant from cell to cell, since it was so fundamental to the cells in transcri
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
13-Sep-2001


Page: 1 2 3

Related biology news :

1. Targeting transcription: New insights into turning genes on
2. UT Southwestern scientists prove certain proteins play unexpected roles in genetic transcription
3. Tidying up transcription factors
4. Post-transcriptional regulation of COX2 in tumor cells
5. Novel means for stopping transcription found, Hopkins scientists report
6. Discovery will change the way researchers look at DNA transcription, scientists say
7. Welch honors Kornberg for insights into DNA transcription
8. Different levels of transcription factor coax immune cell progenitors down different developmental pathways
9. 3-D structure of human transcription factor proteins revealed
10. Sequence of human chromosome 7 is fine-tuned and finished
11. Veterans with Gulf War syndrome have damage in specific, primitive portion of nervous system

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA transcription tuned specific cells

(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)...  EMD Serono today announced the US biopharmaceutical ... , appointed Alise Reicin , MD, ... Development.  Dr. Reicin brings extensive research and early/late ... Immunology. She is an accomplished pharmaceutical executive with ... President in various capacities across R&D at MSD ...
(Date:4/16/2015)... Madison, NJ (PRWEB) April 16, 2015 ... recruited Dr. Joseph V. Gulfo to become the ... and Entrepreneurship. Simultaneously, FDU announced the kick-off of ... new program spearheaded by Dr. Gulfo, under the ... Silberman College of Business) and in collaboration with ...
Breaking Biology Technology:Bioenterprise Corporation Expands into the Maritimes 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
Cached News: